Table 4.
Association between combinations of CagA with VacA seropositivity and risk of gastric adenocarcinoma and its subtypes.
| All gastric adenocarcinoma N (%) |
Controls N (%) |
Adjusted1 OR (95%CI) |
GCA N (%) |
Controls N (%) |
Adjusted1 OR (95%CI) |
GNCA N (%) |
Controls N (%) |
Adjusted1 OR (95%CI) |
|
|---|---|---|---|---|---|---|---|---|---|
| No CagA or VacA | 17 (6.3) | 68 (13.0) | Reference | 12 (8.5) | 30 (10.9) | Reference | 5 (4.9) | 33 (16.9) | Reference |
| VacA only | 11 (4.0) | 47 (9.0) | 0.8 (0.3–2.1) | 5 (3.5) | 26 (9.4) | 0.4 (0.1–1.5) | 4 (3.9) | 14 (7.2) | 1.4 (0.2–7.9) |
| CagA only | 48 (17.6) | 112 (21.4) | 1.6 (0.8–3.3) | 27 (19.0) | 54 (19.6) | 1.2 (0.5–3.1) | 16 (15.5) | 41 (21.0) | 2.1 (0.6–7.1) |
| Both CagA and VacA | 196 (72.1) | 297 (56.6) | 2.8 (1.4–5.3) | 98 (69.0) | 166 (60.1) | 1.6 (0.7–3.8) | 78 (75.7) | 107 (54.9) | 5.1 (1.6–15.9) |
Conditional logistic regression, adjusted for education (illiterate vs. otherwise), ethnicity (Turkmen vs. non-Turkmen), tobacco and opium consumption (ever vs. never), and wealth score as continuous variable.